Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Jan 25, 2023

BUY
$12.74 - $15.12 $700 - $831
55 Added 5.48%
1,059 $0
Q3 2022

Dec 30, 2022

SELL
$12.93 - $17.17 $711 - $944
-55 Reduced 5.19%
1,004 $14,000
Q2 2022

Aug 02, 2022

SELL
$13.53 - $23.34 $3,260 - $5,624
-241 Reduced 18.54%
1,059 $15,000
Q1 2022

Apr 29, 2022

BUY
$16.14 - $22.6 $5,035 - $7,051
312 Added 31.58%
1,300 $29,000
Q4 2021

Jan 06, 2022

SELL
$18.64 - $36.77 $5,573 - $10,994
-299 Reduced 23.23%
988 $19,000
Q3 2021

Oct 29, 2021

SELL
$32.83 - $43.0 $2,166 - $2,838
-66 Reduced 4.88%
1,287 $42,000
Q2 2021

Jul 22, 2021

BUY
$34.41 - $44.03 $11,527 - $14,750
335 Added 32.91%
1,353 $58,000
Q1 2021

Apr 27, 2021

BUY
$37.29 - $47.19 $1,118 - $1,415
30 Added 3.04%
1,018 $39,000
Q1 2019

Apr 23, 2019

BUY
$26.74 - $41.32 $25,403 - $39,254
950 Added 2500.0%
988 $38,000
Q1 2019

Apr 23, 2019

SELL
$26.74 - $41.32 $25,403 - $39,254
-950 Reduced 96.15%
38 $38,000
Q4 2018

Jan 29, 2019

SELL
$25.26 - $38.43 $70,096 - $106,643
-2,775 Reduced 73.74%
988 $28,000
Q3 2018

Oct 15, 2018

BUY
$33.27 - $39.25 $125,195 - $147,697
3,763 New
3,763 $147,000

Others Institutions Holding CSII

About Cardiovascular Systems Inc


  • Ticker CSII
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 41,905,900
  • Description
  • Cardiovascular Systems, Inc., a medical technology company, develops and commercializes solutions to treat peripheral and coronary artery diseases in the United States and internationally. The company offers peripheral artery disease products comprising catheter-based platforms to treat various plaque types in above and below the knee, including...
More about CSII
Track This Portfolio

Track Versant Capital Management, Inc Portfolio

Follow Versant Capital Management, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Versant Capital Management, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Versant Capital Management, Inc with notifications on news.